RXO Shares Surge 304 After Positive Analyst Outlook on Logistics Prospects
Legal Scholars Challenge Trumps 18 Billion Fund Ancient Principles and Modern Precedents
French Investors Shift to Real Assets as Safe Haven in First Quarter
Indias Gen Z Cockroach Movement Gains Momentum Amid Exam Controversy Website Taken Down
Microns Latest Breakthrough Dicks Earnings Beat and Key Political Shifts Lead Market Morning
Senco Gold Q4 Profit Surges 151 to Rs 157 Crore on Strong Gold Prices and Wedding Demand
Xenon Pharmaceuticals XENE Q1 2026 Earnings Narrowerthanexpected loss highlights operational progress
Flowers Foods Q1 2026 Earnings EPS Surges Past Estimates as Stock Jumps 13
Jefferson Capital Inc JCAP Q1 2026 Earnings EPS Beats Estimates but Stock Slides on Mixed Signals
Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings Narrower Net Loss Beats Estimates Amid Pipeline Progress
BMRC Q1 2026 Earnings EPS Misses Estimates as Loan Portfolio Pressures Emerge
Lineage Inc LINE Q1 2026 Earnings EPS Miss Sends Shares Higher Amid Operational Strength
Birchtech Corp BCHT Edges Higher as Shares Test Support Zone
Ingram Micro INGM Surges 338 Key Technical Signals in Play
AGNCN Preferred Stock Holds Steady Near 2574 Amid Narrow Trading Range
Caribou Biosciences CRBU Jumps 7 as GeneEditing Stock Approaches Key Resistance
Splash Beverage Group SBEV Slides 357 to 016 Testing Key Support at 015
Healthcare and Tech Lead as Broad Market Edges Higher
Myriad Genetics Q1 2026 Earnings EPS Miss Highlights Continued Operational Challenges
Lincoln Electric Holdings LECO Edges Higher as Market Digests Steady Industrial Demand
FIGS Inc Edges Higher as Stock Approaches Resistance Zone
Transdigm Group TDG Holds Steady Near Key Support Levels Amid Modest Gains
McKinley Acquisition Corporation Rights MKLYR Surges 40 Rights Trading at 014
BrandywineGLOBAL Global Income Opportunities Fund BWG Holds Steady Near Support as Yield Play Gains Attention
Covista Inc CVSA Slides Marginally Holding Above Key Support
LSI Industries LYTS Surges Nearly 3 as Bulls Approach Key Resistance
Kymera Therapeutics KYMR Holds Near Resistance After Marginal Decline